Teradyne (TER) moved into focus after releasing third quarter 2026 results alongside fresh fourth quarter guidance, combining current performance with a concrete near term outlook that investors can measure against.
Recent trading has been rough for Teradyne, with the share price falling 15.24% over the last day and 48.34% over 30 days. However, the 1 year total shareholder return of 16.94% and the very strong 3 year total shareholder return of 144.05% indicate that longer term momentum remains intact.
Capitalize on the volatility around Teradyne by scanning a curated set of automation and chip testing peers in 90 robotics and automation stocks that could also be reacting to the same earnings momentum.The sharp pullback in Teradyne following strong quarterly results leaves a clear question: Is the recent decline creating new upside potential, or has most of the accessible gain already been realized at the current valuation?
At a last close of $212.74 against a narrative fair value estimate of $424.67, Teradyne is framed as materially undervalued, with that gap resting on a very specific view of how AI test and robotics demand evolve from here.
Rising semiconductor capital intensity and more complex advanced packaging are lifting automated test equipment spending, with test already at about 8% of semiconductor CapEx in early 2026 and management seeing a path for ATE TAM to reach or exceed US$20b, which can support Teradyne revenue growth and operating leverage over time.
See why 119 investors see Teradyne as 50% undervalued.
Result: Fair Value of $424.67 (UNDERVALUED)
Still, this Teradyne story can break if AI related capital spending slows or if higher R&D and go to market costs continue pressuring margins longer than analysts expect.
Find out about the key risks to this Teradyne narrative.
Sentiment around Teradyne is mixed, with clear risks on one side and meaningful potential rewards on the other. Move quickly and weigh the evidence yourself by reviewing the 5 key rewards and 1 important warning sign.
You have seen how Teradyne's story can shift quickly, so do not stop here. Use the Simply Wall Street Screener to find other opportunities that match your approach.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com